Torrent Pharmaceuticals Limited (TORNTPHARM) — Announcement | 11 August 2026 (2 announcements)

11 August 2026 · NSE Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

1Announcement Neutral📄 PDF

📢 Key Event

Company schedules investor meetings under SEBI Regulation 30

💡 Investor Takeaway

Shareholders should note the company is actively engaging institutional investors, which may influence short-term trading activity and liquidity.

Torrent Pharmaceuticals announced its participation in an investors' meet hosted by Emkay on August 14, 2026, in Mumbai, as part of Regulation 30 compliance for SEBI disclosure obligations. The filing confirms scheduled one-on-one and group meetings with institutional investors, subject to change based on company or investor exigencies.

2Announcement Neutral📄 PDF

📢 Key Event

NSE assigns Torrent Pharmaceuticals an ESG rating of 70

💡 Investor Takeaway

The ESG rating underscores Torrent's sustainability efforts and could attract responsible investment.

Torrent Pharmaceuticals announced that NSE Sustainability Ratings and Analytics assigned the company an ESG rating of 70, reflecting its environmental, social, and governance performance. This rating highlights the firm's commitment to sustainable practices and may enhance its appeal to ESG-focused investors.

📊 Stock Analysis — TORNTPHARM ✨ Ask AI About This

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,85,216.32 CrP/E: 77.7ROE: 25.7%ROCE: 15.1%Div Yield: 0.78%

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

💡 Ask AI about this filing

"When will the investor meeting schedule be finalized?""Which analysts are confirmed to attend?""What specific disclosures will be made during the meet?"

Ask AI Free →

📊 More TORNTPHARM filings

Announcement — 28 September 2026Torrent Pharmaceuticals announced that its designated persons' trading window closes on October 1, 2...
🔴 Corporate Action — 28 September 2026Torrent Pharmaceuticals announced an amendment to its share subscription agreement with Torrent Urja...
🔴 Announcement — 10 September 2026Torrent Pharmaceuticals announced its participation in multiple investor meetings scheduled between ...
🟡 Voting Results — 7 September 2026Torrent Pharmaceuticals announced that shareholders approved the appointment of Shanti Ekambaram as ...
🟡 Voting Results — 7 September 2026Torrent Pharmaceuticals announced the outcome of its postal ballot vote on appointing Shanti Ekambar...

See all TORNTPHARM filings →

🔥 Also filed on 11 August 2026

ULTRACEMCOUltraTech Cement LimitedAnnouncement SUDEEPPHRMSudeep Pharma LimitedFinancial Results SUTLEJTEXSutlej Textiles and Industries LimitedFinancial Results RBZJEWELRBZ Jewellers LimitedFinancial Results TATVATatva Chintan Pharma Chem LimitedCorporate Action AETHERAether Industries LimitedCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.